CSD201202: A Study to Assess Nicotine Uptake From Electronic Nicotine Delivery System P12

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
This is an open-label, randomized, 8-way crossover study designed to evaluate plasma nicotine pharmacokinetic (PK) parameters following an ad libitum use of Electronic Nicotine Delivery System (ENDS) investigational products (IPs) in a confinement setting by generally healthy combustible cigarette (CC) smokers and dual users of CC and ENDS.
Epistemonikos ID: aa7fd1728e128e193d284bcd6a32a3c2972eefb0
First added on: May 10, 2024